...组和对照组,治疗前各项评分比较,差异无统计学意义(P>0.05);经过6～8周治疗后,心理干预组和对照组各项评分比较:抑郁量表评分(HMAD)和运动功能评分(FMA)差异有统计学意义(P<0.01),生活能力评分(NFA)和生活能力指数评分(BI)差异有统计学意义(P<0.05).
基于16个网页-相关网页
消痰解郁方可以改善DC并发抑郁患者的临床症状和免疫功能，提高生存质量，降低抑郁量表评分，临床使用安全有效。
XTJYP can improve the clinical symptoms and immune function of the patients with DC concurrent depression, improve the quality of life and reduce depression scales' score, it's safe and effective.
将食管癌兼有抑郁症状的病人随机分为治疗组和对照组，治疗组采用疏肝解郁中药与活血化瘀药交替口服，观察两组抑郁量表评分的变化与局控率、生存率的变化。
Group A was treated with traditional chinese medicine, group B was control one . Changes of SDS scores, local control rate and survival rate were achieved in the two groups.
方法：采用多种量表评分对114例卒中后抑郁患者进行随机、对照并随访1年的前瞻性研究。
Methods:A controlled prospective design was applied in this study of 114 patients with depression after stroke. Several scales were used for functional measure.
应用推荐